A High-Throughput Approach to Identify Specific Neurotoxicants / Developmental Toxicants in Human Neuronal Cell Function Assays

Altex

Volumn 35, Issue 2, 2018, Pages 235-253

  Delp, Johannes ^a   Gutbier, Simon ^a   Klima, Stefanie ^a   Hoelting, Lisa ^a   Pinto Gil, Kevin ^b   Hsieh, Jui Hua ^c   Aichem, Michael ^a   Klein, Karsten ^a   Schreiber, Falk ^a,d   Tice, Raymond R ^e   Pastor, Manuel ^b   Behl, Mamta ^e   Leist, Marcel ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c Kelly Government Solutions Inc   (United States)

^d MONASH UNIVERSITY   (Australia)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

cytotoxicity; developmental toxicity; high content imaging; neurite outgrowth inhibition; neurotoxicity

Indexed keywords

CELL CULTURE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; HIGH THROUGHPUT SCREENING; HUMAN; PROCEDURES; TOXICITY TESTING;

CELLS, CULTURED; DOPAMINERGIC NEURONS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; TOXICITY TESTS;

EID: 85049303762     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.1712182     Document Type: Article

References (80)

1. Aschner, M., Ceccatelli, S., Daneshian, M. et al. (2017). Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: Example lists and criteria for their selection and use. ALTEX 34, 49-74. doi:10.14573/altex.1604201
2. Bal-Price, A., Crofton, K. M., Leist, M. et al. (2015). International stakeholder network (ISTNET): Creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Arch Toxicol 89, 269-287. doi:10.1007/s00204-015-1464-2
3. Balmer, N. V., Weng, M. K., Zimmer, B. et al. (2012). Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum Mol Genet 21, 4104-4114. doi:10.1093/hmg/ dds239
4. 4 report*. ALTEX 29, 3-91. doi:10.14573/altex.2012.1.003
5. Baumann, J., Gassmann, K., Masjosthusmann, S. et al. (2016). Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events. Arch Toxicol 90, 1415-1427. doi:10.1007/s00204-015-1568-8
6. Bennett, D., Bellinger, D. C., Birnbaum, L. S. et al. (2016). Project TENDR: Targeting environmental neuro-developmental risks the TENDR consensus statement. Environ Health Perspect 124, A118-122. doi:10.1289/ehp358
7. Brown, J. P., Lynch, B. S., Curry-Chisolm, I. M. et al. (2017). Assaying spontaneous network activity and cellular viability using multi-well microelectrode arrays. Methods Mol Biol 1601, 153-170. doi:10.1007/978-1-4939-6960-9_13
8. Cavanagh, J. B. (2000). Experimental and clinical neurotoxicology. Second edition. Brain 123, 2571-2573. doi:10.1093/ brain/123.12.2571
9. Crofton, K. M., Mundy, W. R., Lein, P. J. et al. (2011). Developmental neurotoxicity testing: Recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX 28, 9-15. doi:10.14573/altex.2011.1.009
10. Crofton, K. M., Mundy, W. R. and Shafer, T. J. (2012). Developmental neurotoxicity testing: A path forward. Congenit Anom (Kyoto) 52, 140-146. doi:10.1111/j.1741-4520.2012.00377.x
11. Crofton, K., Fritsche, E., Ylikomi, T. et al. (2014). International stakeholder network (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes. ALTEX 31, 223-224. doi:10.14573/altex.1402121
12. Culbreth, M. E., Harrill, J. A., Freudenrich, T. M. et al. (2012). Comparison of chemical-induced changes in proliferation and apoptosis in human and mouse neuroprogenitor cells. Neurotoxicology 33, 1499-1510. doi:10.1016/j.neuro.2012.05.012
13. Daneshian, M., Kamp, H., Hengstler, J. et al. (2016). Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk. Arch Toxicol 90, 1021-1024. doi:10.1007/s00204-016-1698-7
14. Duran, A., Zamora, I. and Pastor, M. (2009). Suitability of GRIND-based principal properties for the description of molecular similarity and ligand-based virtual screening. J Chem Inf Model 49, 2129-2138. doi:10.1021/ci900228x
15. Ezendam, J., Braakhuis, H. M. and Vandebriel, R. J. (2016). State of the art in non-animal approaches for skin sensitization testing: From individual test methods towards testing strategies. Arch Toxicol 90, 2861-2883. doi:10.1007/s00204-016-1842-4
16. Flaskos, J., Nikolaidis, E., Harris, W. et al. (2011). Effects of sub-lethal neurite outgrowth inhibitory concentrations of chlorpyrifos oxon on cytoskeletal proteins and acetylcholinesterase in differentiating N2a cells. Toxicol Appl Pharmacol 256, 330-336. doi:10.1016/j.taap.2011.06.002
17. Frimat, J. P., Sisnaiske, J., Subbiah, S. et al. (2010). The network formation assay: A spatially standardized neurite outgrowth analytical display for neurotoxicity screening. Lab Chip 10, 701-709. doi:10.1039/b922193j
18. Fritsche, E., Cline, J. E., Nguyen, N.-H. et al. (2005). Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: Clue for involvement of thyroid hormone receptors. Environ Health Perspect 113, 871-876. doi:10.1289/ehp.7793
19. Fritsche, E., Crofton, K. M., Hernandez, A. F. et al. (2017). OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes. ALTEX 34, 311-315. doi:10.14573/altex.1701171
20. Grandjean, P. and Landrigan, P. J. (2006). Developmental neurotoxicity of industrial chemicals. Lancet 368, 2167-2178. doi:10.1016/S0140-6736(06)69665-7
21. Grandjean, P. and Landrigan, P. J. (2014). Neurobehavioural effects of developmental toxicity. Lancet Neurol 13, 330-338. doi:10.1016/S1474-4422(13)70278-3
22. Harrill, J. A. and Mundy, W. R. (2011). Quantitative assessment of neurite outgrowth in PC12 cells. Methods Mol Biol 758, 331-348. doi:10.1007/978-1-61779-170-3_23
23. Harrill, J. A., Freudenrich, T. M., Robinette, B. L. and Mundy, W. R. (2011). Comparative sensitivity of human and rat neural cultures to chemical-induced inhibition of neurite outgrowth. Toxicol Appl Pharmacol 256, 268-280. doi:10.1016/j. taap.2011.02.013
24. Harrill, J. A., Robinette, B. L., Freudenrich, T. and Mundy, W. R. (2013). Use of high content image analyses to detect chemical-mediated effects on neurite sub-populations in primary rat cortical neurons. Neurotoxicology 34, 61-73. doi:10.1016/j. neuro.2012.10.013
25. Hartung, T., Luechtefeld, T., Maertens, A. and Kleensang, A. (2013). Food for thought … Integrated testing strategies for safety assessments. ALTEX 30, 3-18. doi:10.14573/ altex.2013.1.003
26. Hoelting, L., Klima, S., Karreman, C. et al. (2016). Stem cell-derived immature human dorsal root ganglia neurons to identify peripheral neurotoxicants. Stem Cells Transl Med 5, 476-487. doi:10.5966/sctm.2015-0108
27. Hogberg, H. T., Kinsner-Ovaskainen, A., Hartung, T. et al. (2009). Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. Toxicol Appl Pharmacol 235, 268-286. doi:10.1016/j.taap.2008.12.014
28. Hogberg, H. T., Kinsner-Ovaskainen, A., Coecke, S. et al. (2010). mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol Sci 113, 95-115. doi:10.1093/toxsci/kfp175
29. Howard, A. S., Bucelli, R., Jett, D. A. et al. (2005). Chlorpyrifos exerts opposing effects on axonal and dendritic growth in primary neuronal cultures. Toxicol Appl Pharmacol 207, 112-124. doi:10.1016/j.taap.2004.12.008
30. Jaworska, J. and Hoffmann, S. (2010). Integrated testing strategy (ITS) – Opportunities to better use existing data and guide future testing in toxicology. ALTEX 27, 231-242. doi:10.14573/altex.2010.4.231
31. Judson, R., Houck, K., Martin, M. et al. (2014). In vitro and modelling approaches to risk assessment from the U.S. Environmental protection agency toxcast programme. Basic Clin Pharmacol Toxicol 115, 69-76. doi:10.1111/bcpt.12239
32. Judson, R. S., Magpantay, F. M., Chickarmane, V. et al. (2015). Integrated model of chemical perturbations of a biological pathway using 18 in vitro high-throughput screening assays for the estrogen receptor. Toxicol Sci 148, 137-154. doi:10.1093/toxsci/kfv168
33. Judson, R., Houck, K., Martin, M. et al. (2016). Analysis of the effects of cell stress and cytotoxicity on in vitro assay activity across a diverse chemical and assay space. Toxicol Sci 152, 323-339. doi:10.1093/toxsci/kfw092
34. Kirkland, D., Reeve, L., Gatehouse, D. et al. (2011). A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res 721, 27-73. doi:10.1016/j.mrgentox.2010.12.015
35. Krug, A. K., Balmer, N. V., Matt, F. et al. (2013). Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Arch Toxicol 87, 2215-2231. doi:10.1007/s00204-013-1072-y
36. +. Cell Death Dis 5, e1222. doi:10.1038/ cddis.2014.166
37. Leist, M., Hartung, T. and Nicotera, P. (2008a). The dawning of a new age of toxicology. ALTEX 25, 103-114. doi:10.14573/ altex.2008.2.103
38. Leist, M., Kadereit, S. and Schildknecht, S. (2008b). Food for thought ... On the real success of 3R approaches. ALTEX 25, 17-32. doi:10.14573/altex.2008.1.17
39. Leist, M., Efremova, L. and Karreman, C. (2010). Food for thought ... Considerations and guidelines for basic test method descriptions in toxicology. ALTEX 27, 309-317. doi:10.14573/altex.2010.4.309
40. Leist, M., Hasiwa, N., Daneshian, M. and Hartung, T. (2012). Validation and quality control of replacement alternatives – Current status and future challenges. Toxicol Res 1, 8-22. doi:10.1039/c2tx20011b
41. Leist, M., Hasiwa, N., Rovida, C. et al. (2014). Consensus report on the future of animal-free systemic toxicity testing. ALTEX 31, 341-356. doi:10.14573/altex.1406091
42. Leontaridou, M., Urbisch, D., Kolle, S. N. et al. (2017). The borderline range of toxicological methods: Quantification and implications for evaluating precision. ALTEX 34, 525-538. doi:10.14573/altex.1606271
43. Lotharius, J., Barg, S., Wiekop, P. et al. (2002). Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277, 38884-38894. doi:10.1074/jbc.M205518200
44. Lotharius, J., Falsig, J., van Beek, J. et al. (2005). Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25, 6329-6342. doi:10.1523/JNEUROSCI.1746-05.2005
45. Makris, S. L., Raffaele, K., Allen, S. et al. (2009). A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect 117, 17-25. doi:10.1289/ehp.11447
46. Marx, U., Andersson, T. B., Bahinski, A. et al. (2016). Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX 33, 272-321. doi:10.14573/altex.1603161
47. Milletti, F., Storchi, L., Sforna, G. and Cruciani, G. (2007). New and original pKa prediction method using grid molecular interaction fields. J Chem Inf Model 47, 2172-2181. doi:10.1021/ci700018y
48. Mundy, W. R., Padilla, S., Breier, J. M. et al. (2015). Expanding the test set: Chemicals with potential to disrupt mammalian brain development. Neurotoxicol Teratol 52, 25-35. doi:10.1016/j.ntt.2015.10.001
49. Nyffeler, J., Dolde, X., Krebs, A. et al. (2017a). Combination of multiple neural crest migration assays to identify environmental toxicants from a proof-of-concept chemical library. Arch Toxicol 91, 3613–3632. doi:10.1007/s00204-017-1977-y
50. Nyffeler, J., Karreman, C., Leisner, H. et al. (2017b). Design of a high-throughput human neural crest cell migration assay to indicate potential developmental toxicants. ALTEX 34, 75-94. doi:10.14573/altex.1605031
51. OECD (2007). Test No. 426: Developmental Neurotoxicity Study. Paris, France: OECD Publishing. doi:10.1787/9789264067394en
52. Pamies, D., Barreras, P., Block, K. et al. (2016). A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity. ALTEX 34, 362-376. doi:10.14573/altex.1609122
53. Paparella, M., Daneshian, M., Hornek-Gausterer, R. et al. (2013). Uncertainty of testing methods – What do we (want to) know? ALTEX 30, 131-144. doi:10.14573/altex.2013.2.131
54. Paparella, M., Colacci, A. and Jacobs, M. N. (2017). Uncertainties of testing methods: What do we (want to) know about carcinogenicity? ALTEX 34, 235-252. doi:10.14573/ altex.1608281
55. Pastor, M., Cruciani, G., McLay, I. et al. (2000). Grid-independent descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors. J Med Chem 43, 3233-3243. doi:10.1021/jm000941m
56. Pei, Y., Peng, J., Behl, M. et al. (2016). Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes. Brain Res 1638, 57-73. doi:10.1016/j. brainres.2015.07.048
57. Prinsen, M. K., Hendriksen, C. F., Krul, C. A. and Woutersen, R. A. (2017). The isolated chicken eye test to replace the Draize test in rabbits. Regul Toxicol Pharmacol 85, 132-149. doi:10.1016/j.yrtph.2017.01.009
58. Ryan, K. R., Sirenko, O., Parham, F. et al. (2016). Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity. Neurotoxicology 53, 271-281. doi:10.1016/j.neuro.2016.02.003
59. Sadowski, J., Gasteiger, J. and Klebe, G. (1994). Comparison of automatic three-dimensional model builders using 639 x-ray structures. J Chem Inf Comput Sci 34, 1000-1008. doi:10.1021/ci00020a039
60. Schildknecht, S., Poltl, D., Nagel, D. M. et al. (2009). Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicol Appl Pharmacol 241, 23-35. doi:10.1016/j. taap.2009.07.027
61. Schildknecht, S., Karreman, C., Poltl, D. et al. (2013). Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases. ALTEX 30, 427-444. doi:10.14573/altex.2013.4.427
62. Schildknecht, S., Di Monte, D. A., Pape, R. et al. (2017). Tipping points and endogenous determinants of nigrostriatal degeneration by MPTP. Trends Pharmacol Sci 38, 541-555. doi:10.1016/j.tips.2017.03.010
63. Schmidt, B. Z., Lehmann, M., Gutbier, S. et al. (2017). In vitro acute and developmental neurotoxicity screening: An overview of cellular platforms and high-throughput technical possibilities. Arch Toxicol 91, 1-33. doi:10.1007/s00204-016-1805-9
64. Schmuck, M. R., Temme, T., Dach, K. et al. (2017). Omnisphero: A high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro. Arch Toxicol 91, 2017-2028. doi:10.1007/s00204-016-1852-2
65. Scholz, D., Poltl, D., Genewsky, A. et al. (2011). Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem 119, 957-971. doi:10.1111/j.1471-4159.2011.07255.x
66. Shinde, V., Hoelting, L., Srinivasan, S. P. et al. (2017). Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: Introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol 91, 839-864. doi:10.1007/s00204-016-1741-8
67. Sirenko, O., Grimm, F. A., Ryan, K. R. et al. (2017). In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model. Toxicol Appl Pharmacol 322, 60-74. doi:10.1016/j. taap.2017.02.020
68. st century and in vitro opportunities. ALTEX 31, 129-156. doi:10.14573/ altex.1403271
69. Smirnova, L., Harris, G., Delp, J. et al. (2016). A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis. Arch Toxicol 90, 2725-2743. doi:10.1007/s00204-015-1637-z
70. Spencer, P. S. and Schaumburg, H. H. (1975). Nervous system degeneration produced by acrylamide monomer. Environ Health Perspect 11, 129-133. doi:10.1289/ehp.7511129
71. Stiegler, N. V., Krug, A. K., Matt, F. and Leist, M. (2011). Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. Toxicol Sci 121, 73-87. doi:10.1093/toxsci/kfr034
72. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S. et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147. doi:10.1126/science.282.5391. 1145
73. Tice, R. R., Austin, C. P., Kavlock, R. J. and Bucher, J. R. (2013). Improving the human hazard characterization of chemicals: A Tox21 update. Environ Health Perspect 121, 756-765. doi:10.1289/ehp.1205784
74. van Thriel, C., Westerink, R. H., Beste, C. et al. (2012). Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. Neurotoxicology 33, 911-924. doi:10.1016/j.neuro.2011.10.002
75. Wishart, D. S., Knox, C., Guo, A. C. et al. (2008). Drugbank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36, D901-D906. doi:10.1093/nar/gkm958
76. Yang, D., Kania-Korwel, I., Ghogha, A. et al. (2014). PCB 136 atropselectively alters morphometric and functional parameters of neuronal connectivity in cultured rat hippocampal neurons via ryanodine receptor-dependent mechanisms. Toxicol Sci 138, 379-392. doi:10.1093/toxsci/kft334
77. Zimmer, B., Kuegler, P. B., Baudis, B. et al. (2011a). Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death Differ 18, 383-395. doi:10.1038/cdd.2010.109
78. Zimmer, B., Schildknecht, S., Kuegler, P. B. et al. (2011b). Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure. Toxicol Sci 121, 357-367. doi:10.1093/toxsci/kfr054
79. Zimmer, B., Lee, G., Balmer, N. V. et al. (2012). Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells. Environ Health Perspect 120, 1116-1122. doi:10.1289/ ehp.1104489
80. Zimmer, B., Pallocca, G., Dreser, N. et al. (2014). Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery. Arch Toxicol 88, 1109-1126. doi:10.1007/s00204-014-1231-9